Company fact sheet
Ticker
MRK
Name
We are called MSD everywhere outside of the U.S. and Canada. In the U.S. and Canada, we are known as Merck & Co., Inc., Kenilworth, N.J., USA. The company is listed on the New York Stock Exchange under the symbol “MRK.”
Description
For more than 125 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.
Today, we continue to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases, such as HIV and Ebola, and emerging animal diseases.
Employees
Approximately 71,000 (as of Dec. 31, 2019)
Headquarters
Kenilworth, New Jersey, USA
Businesses
Pharmaceuticals
Vaccines
Animal Health
2019 Revenue
$46.8 billion
2019 Revenues
(by geographic area, including pharmaceutical and animal health revenue)
| $20.3 B | United States |
| $12.7 B | Europe, Middle East and Africa |
| $ 3.6 B | Japan |
| $ 2.9 B | Asia Pacific (other than Japan and China) |
| $ 2.5 B | Latin America |
| $ 3.2 B | China |
| $ 1.6 B | Other |
2019 R&D expenses
$9.9 billion
Products
MSD is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products.
Pipeline
MSD has a robust pipeline, with a wide range of product candidates across each phase of development.
Senior leadership
Kenneth C. Frazier, chairman of the board, president and chief executive officer
